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radiographic score (mean joint score of 474-10.4 vs. 20.264-8.2). 
RF and anti- CCP antibodies were absent in all patients. There 
was a trend for higher CRP in cases (mean level of 0.905 mg/dl 
4- 1.35) compared to controls (mean level of 0.272 mg/d14-0.22). 
Of significance, there was a correlation of CRP with higher radio- 
graphic score (p of 0.071). Sera from 10 patients was evaluated 
for COME There was no difference in levels between cases and 
controls (cases 11.1 U/L4-4.13, controls 12.36U/L4- 1.38). 
Conclusion: Erosive hand OA may represent a distinct subset 
of OA. In spite of significant erosive disease in these individuals, 
both RF and anti- CCP antibodies were negative, corroborating 
recent findings. Further evaluation of COMP in this population, 
particularly accounting for the overall burden of OA, is warranted. 
The trend towards elevated CRP in the erosive hand OA suggests 
that this may represent a systemic inflammatory disorder. 
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Aim of the study: To determine Coil 2-1 level, a peptide of type II 
collagen triple helix, and its nitrated form (Coil 2-1 NO2) in serum 
of patients with knee or hip osteoarthritis (OA) before and three 
months after knee or hip replacement. 
Methods: Coil 2-1 and Coil 2-1 NO2 were measured by two 
specific competitive immunoassays in 35 healthy subjects and 
in 44 patients with knee or hip OA candidates for joint re- 
placement. Sera were taken the day before the surgery and 
three months after the hip or knee replacement. The immunoas- 
says were specific for a peptide of the helical region of type 
II collagen, l°SHRGYPGLDG116 (Coil 2-1), and its nitrated form 
1°SHRGY(NO2)PGLDG116 (Coil 2-1 NO2), respectively. 
Results: Before surgery, Coil 2-1 and Coil 2-1 NO2 levels were 
higher in serum of OA patients than in healthy subjects of the 
same range of age [Coil 2-1:175.30 4- 11.10 nM vs 133.11 4- 7.86 
nM (p<0.01) and Coil 2-1 NO2:0.94 4- 0.09 nM vs 0.49 4- 0.03 
nM (p< 0.001)]. Three months after hip or knee replacement, Coil 
2-1 concentration in serum of OA patients decreased below the 
level of the healthy subjects [86.99 4- 5.36 nM vs 133.11 4- 7.86 
nM (p<0.001)]. Moreover, a significant correlation between Coil 
2-1 levels in OA patients before and after hip or knee replacement 
has been found (r = 0.43, p=0.009). In contrast, Coil 2-1 NO2 
serum level did not vary after surgery (0.75 4- 0.05 nM). 
Conclusions: These findings suggest that Coil 2-1 and Coil 2- 
1 NO2 are interesting markers for detection of late structural 
change in OA patients. Furthermore, the decrease of Coil 2-1 
after surgery and the correlation between pre- and post-surgery 
serum levels of Coil 2-1 suggest that Coil 2-1 is a disease-specific 
marker. 
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Aim of Study: A major and early feature of cartilage degenera- 
tion is proteoglycan breakdown. MMP-13 plays an important role 
in osteoarthritic (OA) cartilage degradation. This MMP, in addition 
to initiating collagen fiber cleavage, also acts on several proteo- 
glycans. Among the proteoglycan families, one termed the small 
leucine-rich proteoglycans (SLRPs) was found to be involved in 
collagen fibril formation/interaction, with some members demon- 
strating a role in the OA process. We investigated the ability of 
MMP-13 to cleave members of two classes of SLRPs: 1) bigly- 
can and decorin and 2) fibromodulin and lumican. 
Methods: SLRPs were isolated from human normal and OA car- 
tilage using guanidinium chloride (4 M) extraction. Digestion prod- 
ucts were examined by Western blotting. The identity of the MMP- 
13 degradation products of biglycan (using specific substrate) 
was determined following electrophoresis and microsequencing. 
Results: We showed that the SLRPs studied were cleaved to dif- 
fering extents by human MMP-13. Although only minimal cleav- 
age of decorin and lumican was observed, cleavage of fibromod- 
ulin and biglycan was extensive, suggesting that both molecules 
are preferential substrates. In contrast to decorin, and lumican, 
which yielded a similar degradation pattern for both normal and 
OA, biglycan, but particularly fibromodulin, had a higher level of 
degradation with increased cartilage damage. Microsequencing 
revealed a novel major cleavage site (... VPK178-179VFS) for 
biglycan upon exposure to MMP-13. 
Conclusion: We showed, for the first time, the ability of MMP-13 
to degrade members from two classes of the SLRP family, and 
the site at which biglycan is cleaved by MMP-13. The MMP-13- 
induced SLRP degradation may represent an early critical event, 
which may in turn affect the collagen network by the exposure 
of the MMP-13 cleavage site in this macromolecule. Awareness 
of the SLRP degradation products, especially those of biglycan 
and fibromodulin, may assist in early detection of OA cartilage 
degradation. 
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Aim: Chondrocyte hypertrophy, a mediator of OA progression, is 
associated with an upregulation of the transglutaminases FXlIIA 
and transglutaminase 2 (TG2), so we examined the potential role 
of FXlIIA in promoting hypertrophy, an activity recently demon- 
strated for TG2. 
Methods: We employed RNAi knockdown of FXIIIA and TG2 
in cultured normal human knee articular chondrocytes. Primary 
knee chondrocytes also were isolated from TG2 +/+ and TG2- 
/- mice. Recombinant wild type FXlIIA and point mutants were 
generated to examine the need for the defined thrombin activa- 
tion and inactivation endoproteolytic sites, the transamidation cat- 
alytic site, the cation binding site, the isomerization site and the 
calcium binding domain. Bovine articular cartilage explants also 
were treated with recombinant TG2 and FXlIIA for examination of 
type X collagen expression. Finally, human articular chondrocytes 
were transfected and stimulated with recombinant TG2 and FXl- 
IIA to determine xtracellular TG2 levels by ELISA, expression of 
type X collagen and phosphorylation of p38 MAPK. 
Results: Recombinant wild type FXlIIA (100 ng/ml) induced 
chondrocyte hypertrophy, an activity dependent on both TG2 ex- 
pression and of TG2 externalization, as confirmed using TG2 -/- 
knee chondrocytes. FXlIIA did not act by directly binding or chap- 
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eroning TG2 out of the chondrocyte cytosol. Recombinant TG2, 
but not IL-8, retinoic acid or recombinant FXlIIA, retained the ca- 
pacity to induce chondrocyte hypertrophy in FXlIIA knocked-down 
chondrocytes. During chondrocyte maturation in vitro, immuocy- 
tochemistry revealed distinct populations of FXlllA-staining non- 
enlarged cells early in the process, and enlarged TG2-staining 
cells late in the process, suggesting networking between distinct 
cell subsets. Stimulation of bovine cartilage explants revealed 
correlations with Iocalizations of FXlIIA and TG2 and the pattern 
of type X collagen expression. Expression of FXlIIA cDNA point 
and truncation mutants, and stimulation with recombinant soluble 
FXlIIA, revealed the necessity for an intact calcium-binding do- 
main Thr458-Glu495for FXlIIA to induce chondrocyte hypertrophy. 
FXlIIA Ala 457, one of the amino acids demonstrated to directly 
bind calcium, also was essential for induction of TG2 release and 
chondrocyte maturation. Last, exogenous wild type FXlIIA stimu- 
lated the activation of p38, a known signal transducer of chondro- 
cyte hypertrophy, and did so dependent upon FXlIIA Ala 457. 
Conclusions: FXlIIA expression transduces chemokine and 
retinoic acid-induced chondrocyte hypertrophy. FXlIIA induction 
of hypertrophic differentiation depends on FXlIIA having a com- 
plete calcium binding domain (Thr458Glu495), Ala 457, to bind cal- 
cium directly through its main chain oxygen, and the release of 
TG2. Our findings suggest that a subset of FXlllA-expressing 
chondrocytes networks with distinct TG2-expressing cells to pro- 
mote chondrocyte maturation in OA cartilage that mediates dis- 
ease progression. 
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It is still largely unknown what causes osteoarthritis (OA). How- 
ever, it is thought hat developmental processes important in em- 
bryonic development are recapitulated in osteoarthritic cartilage. 
Several members of the wnt and frizzled (Fzd) families are in- 
volved in embryonic development of cartilage and bone. 
Aim of study: To perform a longitudinal expression analysis of 
wnt/Fzd- and related genes during development of an experimen- 
tal model for OA and to verify the expression of selected genes in 
human tissue obtained from knee replacement surgery. 
Methods: Experimental OA was induced by injecting collagenase 
intra-articularly into murine knee joints twice on alternate days, 
thus causing local instability. Cartilage and synovial tissue were 
isolated at 7 days, 21 days and 42 days after induction, mRNA 
was isolated and analyzed using Taqman Low Density Arrays, to 
determine the expression level of 48 genes (Table1) in 8 sam- 
ples simultaneously. Expression of selected genes was tested on 
cartilage from human OA and control patients. 
Results: Several genes from the wnt and Fzd families, as well as 
genes that are involved in wnt-signaling, were regulated in the OA 
model. Wnt-induced secreted protein-1 (WISP-l) was strongly 
upregulated compared to control (left) knee joints. In the syn- 
ovium, expression of WISP1 at day 7, 21 and 42 was increased 
39-fold, 16-fold and 9-fold respectively. In the cartilage, WISP1 
expression was significantly increased at day 7 and 21 (2.5-fold 
and 2.8-fold respectively). In a model for acute arthritis, WISP1 
was not regulated in the cartilage, indicating specificity for OA 
processes. 
In the OA synovium, wnt16 and wnt2b were also strongly upreg- 
ulated at day 7, 21 and 42, (128-, 180- and 90-fold and 80-, 8 
and 1-fold respectively). The increased cartilage expression of 
WISP1 in experimental OA was validated in human OA cartilage. 
In concordance with the experimental OA, WISP1 expression in 
human knee joint cartilage was significantly upregulated (2.65 
fold, p<0.03) compared to control cartilage. 
Table 1. Determined genes 
Frizzled WNT 
Marker genes WNT genes genes related genes 
ADAMTS4 IL-18 
BMP4 IL-lb 
Coil Xal IL-6 
Coil la2 MMP-13 
Coil Ilal TGFb3 
Axin2 LRP6 Fzd3 Fzd7 Wnt2b Wnt7b 
Dickkopf3 Sfrpl Fzd4 Fzd8 Wnt2 Wnt8a 
Dishevelled 1 Sfrp2 Fzd5 Fzdl0 Wnt3a Wnt8b 
Frzb Siah2 Fzd6 Wnt3b Wntl0a 
Indian Hedgehog Wisp1 Wnt4 Wntl0b 
LRP5 Wnt5a Wntl 1 
Wnt5b Wnt14 
Wnt6 Wnt15 
Wnt7a Wnt16 
Conclusions: These results show that during experimental OA, 
Wnt-related processes are regulated as was indicated by the 
markedly increased synovial expression of wnt2b and wntl 6. An- 
other strong indication is the enhanced expression of WISP1 
in synovium and cartilage. This does not only signify that wnt- 
signaling pathways are activated, but it also indicates that the in- 
creased expression of WISP1 may have inhibiting effects on ma- 
trix production by chondrocytes in OA cartilage, since it has been 
described that WISP1 can inhibit the matrix producing chondro- 
cyte phenotype. 
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Aim: Signals generated by the extracellular matrix and by growth 
factors promote cell survival. Loss of survival signals during the 
development of arthritis could contribute to the death of chondro- 
cytes which has been observed in cartilage in OA and inflamma- 
tory arthritis. The aim of this study was to better define signaling 
mechanisms responsible for chondrocyte cell death under con- 
ditions where matrix and growth factor survival signals are defi- 
cient. 
Methods: A model system was developed to deprive chondro- 
cytes of growth factor and matrix signals. Chondrocytes were re- 
moved from normal human articular cartilage by enzymatic di- 
gestion and plated at low density (to reduce autocrine/paracrine 
growth factor signaling) in serum-free media on poly-L-lysine (no 
matrix signals) or fibronectin (FN) as a matrix control. Survival 
was assessed after 24 hours in the presence of nM to I~M doses 
of a panel of over 50 inhibitors of various signaling pathways as 
well as reagents that modify reactive oxygen species (ROS) pro- 
duction. 
Results: Significant cell death (60% of the plated cells) was 
noted on poly-L-lysine while no cell death was noted under similar 
culture conditions with cells plated on FN. Cells on poly-L-lysine 
had a 2-fold increase in ROS production, measured using a flu- 
orescent probe (DCFDA), compared to cells on FN. Cell death 
on poly-L-lysine could be completely inhibited with the addition 
of either antioxidants (Tiron, MnTBAP, or N-acetyl-cysteine) or 
inhibitors of specific protein kinase C (PKC) isoforms including 
